Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -79.50% | 246.57% | 246.67% | -12.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -79.50% | 246.57% | 246.67% | -12.18% |
| Cost of Revenue | -- | -83.38% | 156.74% | 156.74% | 16.76% |
| Gross Profit | -- | -69.62% | 39.68% | 39.89% | -32.19% |
| SG&A Expenses | -- | -60.05% | 218.96% | 218.39% | -4.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -90.53% | 71.56% | 98.11% | 564.90% |
| Total Operating Expenses | -- | -78.16% | 207.43% | 207.52% | 10.45% |
| Operating Income | -- | -98.46% | -68.31% | -68.39% | -78.73% |
| Income Before Tax | -- | -220.54% | -155.17% | -155.07% | -115.57% |
| Income Tax Expenses | -- | -463.85% | -292.90% | -302.05% | -122.62% |
| Earnings from Continuing Operations | -- | -208.67% | -146.82% | -146.55% | -113.15% |
| Earnings from Discontinued Operations | -- | -- | 48.70% | 46.97% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -84.93% |
| Net Income | -- | -174.97% | -120.74% | -120.78% | -52.19% |
| EBIT | -- | -98.46% | -68.31% | -68.39% | -78.73% |
| EBITDA | -- | -93.41% | -83.05% | -83.39% | -67.91% |
| EPS Basic | -- | -169.39% | -116.47% | -118.12% | -55.17% |
| Normalized Basic EPS | -- | -250.17% | -163.20% | -111.95% | -134.64% |
| EPS Diluted | -- | -168.64% | -114.44% | -116.09% | -52.31% |
| Normalized Diluted EPS | -- | -250.17% | -163.20% | -111.95% | -134.64% |
| Average Basic Shares Outstanding | -- | 5.24% | 3.52% | 2.76% | 0.15% |
| Average Diluted Shares Outstanding | -- | 5.24% | 3.52% | 2.76% | 0.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -1.02% | -1.02% | -0.99% |